Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

NDORMS PhD student Akira Wiberg won the main prize of this year's Max Perutz Science Writing Award. The MRC-funded student received the first prize of £1,500 for his article: "Getting on your nerves", at the awards ceremony on 15 October.

Horizontal portrait of Akira Wiberg

Award-winner Akira Wiberg said: "I'm utterly delighted. It was unexpected so a very pleasant surprise and I'm very pleased that the disease I'm studying - carpal tunnel syndrome - has got a bit of publicity today, because it's very debilitating and important for society. I'm hoping to tread a career as a surgeon scientist. I'm currently a plastic surgery trainee but I want to carry on doing my clinical work alongside research and I think communicating my research with the public is very important. This is my first step in doing that."

Akira's research focusses on understanding the genetic basis of Carpal Tunnel Syndrome, and ultimately shed light on the pathophysiology of nerve injury through compression. The prevalence of the condition in the UK is 7–16%.

The awards were announced by the MRC's Executive Chair Professor Fiona Watt, who chaired the judging panel, and fellow judge Andy Ridgeway, journalist and Senior Lecturer in Science Communication at the University of the West of England in Bristol.

Fiona said: “This is the second year that I have chaired the judging panel of our Max Perutz Award. It is a really enjoyable experience. From this year’s set of 116 entries, we shortlisted 12 outstanding writers. Their articles represent the fantastic breadth of research we fund – from discovery research to clinical studies and development of new technologies. Topics include disease prevention, precision medicine and new ways to treat mental health conditions and tackle antimicrobial resistance.

"Using conversational language, relatable anecdotes and personal experiences, the writers grab the reader’s attention, explaining simply and clearly why their research matters. I’m proud to say that previous winners have gone on to win national science writing awards, give TED talks and become BBC presenters. Encouraging our researchers to make their science accessible to non-scientists is more important than ever to help us secure public and government support for life-changing research. For many entrants this was their first step along that journey – I wish them every success in future."

Dr Roger Highfield, MRC Council member and Science Director of the Science Museum Group, was the third member of the judging panel. Commenting on the importance of good science communication he said: “We need to build public acceptance and enthusiasm for what scientists do if research is to thrive. I really enjoyed judging the Max Perutz Award, which provides a panoramic glimpse of the epic range of MRC-funded research and encourages embryonic writing talent.

“This research was funded by the public, so we have to explain how the money has been spent and why. It is critical that young scientists learn how to write in a way that can grab the interest of non-specialist so they have the opportunity to explain why their work really matters in a way that any taxpayer can understand.”

Before the ceremony the shortlisted entrants had the chance to attend a science writing masterclass led by Dr Claire Ainsworth, freelance journalist and science writer. During the afternoon session, the shortlisters learnt about the principles of effective popular-style science writing and tried their hand at editing each other’s articles.

The award is named in honour of one of the UK’s most outstanding scientists and communicators, Dr Max Perutz. Max, who died in 2002, was awarded the 1962 Nobel Prize in Chemistry and was the founder and first chairman of the MRC Laboratory of Molecular Biology (LMB) in Cambridge. Max was also a keen and talented communicator who inspired countless students to use everyday language to share their research with the people whose lives are improved by their work.

This year's shortlisted articles are now published (PDF, 1.35MB). Read Akira's winning article on our blog.

Max Perutz Science Writing Award 2019

Similar stories

NDORMS researchers awarded for Dupuytren research

Awards Hand Kennedy Main

Three NDORMS researchers have received awards from the International Dupuytren Society, a patient organisation that brings together Dupuytren Disease patient societies from across the world.

Hope for rheumatoid arthritis patients who are non-responsive to anti-TNF

Arthritis Kennedy Main

New research published in The Lancet shows that tocilizumab is a more effective treatment than rituximab for rheumatoid arthritis patients with a poor response to anti-tumour necrosis factor (TNF).

A new study maps the expression of innate immune receptors during the course of arthritis

Arthritis Kennedy Main

The research, which was a collaboration with researchers from Oxford University and Queen Mary University of London and published in Journal of Autoimmunity, looked at changes in receptors known as toll-like receptors (TLRs) in arthritis at different stages of disease.

International Women's Day

Department Main

It’s International Women's Day! This year’s theme is #Choosetochallenge. We’re celebrating some of the amazing women at NDORMS, and asking them what changes they’d like to see in medical sciences over the next 100 years.

Patients and carers invited to join new group helping to shape research and treatment of bones, muscles and joints

Main PPI

Oxford’s newest patient partner group, OPEN ARMS launches today to explore the causes, treatment and care for patients with musculoskeletal conditions. Its first three patient partners explain why they are involved and invite other members of the public to join the team.

NDORMS academics named NIHR Senior Investigators

Main

Congratulations to Professor Jonathan Rees who has been announced as a National Institute of Health Research (NIHR Senior Investigator).